Rphylo 1% w/v PFS Injection 6 ml

Rphylo 1% w/v PFS Injection 6 ml is a non-steroidal anti-inflammatory drugs (NSAIDs) used in the treatment of knee pain due to osteoarthritis. It is a degenerative joint disease in which the two ends of the joints come together due to the breakdown of a protective covering of cartilage.

Rphylo 1% w/v PFS Injection 6 ml contains Sodium hyaluronate, which works by restoring synovial fluid in the knee that helps to lubricate and cushion the joint during movement. Thereby it reduces pain.

Rphylo 1% w/v PFS Injection 6 ml will be administered by a healthcare professional; do not self-administer. In some cases, you may experience certain common side effects such as pain, swelling, redness, and warmth at the injection site or fluid in the joint. If the side effects persist or worsen, please consult your doctor.

If you are allergic to Sodium hyaluronate or products from birds such as eggs, feathers and poultry, inform your doctor before receiving Rphylo 1% w/v PFS Injection 6 ml. Rphylo 1% w/v PFS Injection 6 ml is not recommended for children, pregnant or breastfeeding woman and should be used with caution in patients with pre-existing chondrocalcinosis (accumulation of calcium salts in hyaline cartilage or fibrocartilage) as it may lead to an acute attack of the condition.

Rphylo 1% w/v PFS Injection 6 ml is indicated in the treatment of Osteoarthritis. The detailed uses are as follows:

• Treats osteoarthritis: Rphylo 1% w/v PFS Injection 6 ml helps manage osteoarthritis, a joint condition. It works by restoring synovial fluid in the knee that helps to lubricate and cushion the joint during movement. 

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Rphylo 1% w/v PFS Injection 6 ml will be administered by the doctor or healthcare professional.
• Do not self-administer.

• Rphylo 1% w/v PFS Injection 6 ml contains Sodium hyaluronate, a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of knee pain due to osteoarthritis.
• Rphylo 1% w/v PFS Injection 6 ml is mainly used in patients who have failed to respond adequately to simple painkillers or physical therapy and exercise.
• Rphylo 1% w/v PFS Injection 6 ml works by restoring synovial fluid in the knee that helps to lubricate and cushion the joint during movement. Thereby it reduces pain by decreasing friction in the joints.
• Rphylo 1% w/v PFS Injection 6 ml is administered by a health professional.

• Inform your doctor before receiving Rphylo 1% w/v PFS Injection 6 ml if you are allergic to Sodium hyaluronate or products from birds such as eggs, feathers and poultry.
• If you are a pregnant or breastfeeding woman, inform your doctor before receiving Rphylo 1% w/v PFS Injection 6 ml.
• Rphylo 1% w/v PFS Injection 6 ml is not recommended for children as safety and effectiveness have not been established.
• Rphylo 1% w/v PFS Injection 6 ml should be used with caution in patients with pre-existing chondrocalcinosis (accumulation of calcium salts in hyaline cartilage or fibrocartilage) as it may lead to an acute attack of the condition.
• Avoid activities such as tennis, heavy lifting, jogging, or standing on your feet for a long time immediately after receiving Rphylo 1% w/v PFS Injection 6 ml and for the next 48 hours.